Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer

Breast Cancer Research and Treatment

Volumn 102, Issue 1, 2007, Pages 111-117

  Greenlee, Heather ^a   Chen, Yu ^b   Kabat, Geoffrey C ^c   Wang, Qiao ^a   Kibriya, Muhammad G ^a   Gurvich, Irina ^a   Sepkovic, Daniel W ^d   Bradlow, H Leon ^d   Senie, Ruby T ^a,e   Santella, Regina M ^a,e   Ahsan, Habibul ^a,e  

^a Columbia University ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

16 Hydroxyestrone; 2 Hydroxyestrogens; Breast cancer; Polymorphisms related to estrogen biosynthesis metabolism; Urinary estrogen metabolites

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTROGEN; AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17; CYTOCHROME P450 1B1; ESTROGEN; ESTROGEN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER REGISTRY; CODON; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; URINALYSIS; URINE LEVEL;

ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CODON; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; HYDROXYESTRONES; MIDDLE AGED; POLYMORPHISM, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 33847111110     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9308-7     Document Type: Article

References (15)

1. Bernstein L, Ross RK (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65
2. Zeleniuch-Jacquotte A, Shore RE, Koenig KL et al (2004) Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90:153-159
3. Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27
4. Bradlow HL, Davis DL, Lin G et al (1995) Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Health Perspect 103(Suppl 7):147-150
5. Fishman J, Martucci C (1980) Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 51:611-615
6. Schneider J, Huh MM, Bradlow HL et al (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259:4840-4845
7. Thompson PA, Ambrosone C (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27:125-134
8. Mitrunen K, Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544:9-41
9. Tworoger SS, Chubak J, Aiello EJ et al (2004) Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:94-101
10. Lurie G, Maskarinec G, Kaaks R et al (2005) Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 14:1521-1527
11. Paracchini V, Pedotti P, Raimondi S et al (2005) A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. Clin Chem Lab Med 43:702-706
12. Bradlow HL, Sepkovic DW, Klug T et al (1998) Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 63:406-413
13. Ahsan H, Chen Y, Whittemore AS et al (2004) A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121-131
14. Ahsan H, Whittemore AS, Chen Y et al (2005) Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study. Breast Cancer Res 7:R71-R81
15. Xu X, Duncan AM, Merz-Demlow BE et al (1999) Menstrual cycle effects on urinary estrogen metabolites. J Clin Endocrinol Metab 84:3914-3918